Lisa Obrien
Family · Franklin, WINPI 1174980098
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,302 of the $6,842 with a category attached, or 77.5%. 26 manufacturers reported payments, led by Medtronic at 39.8% of the total. Reporting peaked in 2023 at $3,197 and has fallen 65.8% since, to $1,093 in 2025. Among family clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $35.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Nevro Corp.$967
- Collegium Pharmaceutical, Inc.$628
- Boston Scientific$433
- Abbott$406
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$403
- plus $1K from 20 others
What the payments were for
- Travel & lodging$1,47622%
- Food & beverage$5,30278%
- Education$631%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 41 | $2,720 |
| Nevro Corp. | 26 | $967 |
| Collegium Pharmaceutical, Inc. | 34 | $628 |
| Boston Scientific | 11 | $433 |
| Abbott | 11 | $406 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $403 |
| Tersera Therapeutics LLC | 12 | $286 |
| Spinal Simplicity, LLC | 1 | $159 |
| Vertos Medical, Inc. | 1 | $121 |
| Almatica Pharma LLC | 6 | $106 |
| Averitas Pharma Inc. | 2 | $90 |
| Vertex | 3 | $81 |
| Si-bone, Inc. | 1 | $64 |
| Saluda Medical Americas, Inc. | 1 | $58 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| Avanos Medical | 2 | $45 |
| Fidia Pharma USA Inc. | 2 | $43 |
| Valinor Pharma, LLC | 2 | $41 |
| AbbVie | 1 | $32 |
| Amgen | 1 | $20 |
| Convatec Inc. | 1 | $18 |
| Piramal Critical Care | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
| USWM, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,505
- INTELLIS ADAPTIVESTIM$437
- Senza$317
- Intracept$263
- Omnia$225
- HA MINUTEMAN G3-R$159
- mild Device Kit$121
- SUPERION$117
- PROCLAIM$110
How this compares
$6,842 in reported general payments places this provider in the 95th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 60 | $37,663 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 908 | $28,596 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 785 | $27,462 |
| NucyntaTapentadol Hcl | 22 | $25,133 |
| Nucynta ErTapentadol Hcl | 24 | $24,370 |
| Xtampza ErOxycodone Myristate | 46 | $22,330 |
| Buprenorphine | 81 | $18,180 |
| OxycontinOxycodone Hcl | 24 | $12,557 |
| Pregabalin | 191 | $8,625 |
| Gabapentin | 360 | $8,033 |
| Fentanyl | 61 | $4,841 |
| Morphine Sulfate ErMorphine Sulfate | 214 | $4,731 |
| Diclofenac Sodium | 44 | $3,504 |
| Lidocaine | 30 | $2,864 |
| Tramadol Hcl | 180 | $2,583 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Nucynta Er, Xtampza Er | $628 | $109,496152 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,273 family providers in Wisconsin.
Other family in Franklin
- Stephanie OffordMilwaukee$116K
- Laura SwobodaMenomonee Falls$111K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
- Sarah EmmerichMilwaukee$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.